New Jersey Attorneys Who Get Results

New Jersey Attorney, New Jersey Medical Malpractice Attorney, NJ Personal Injury Lawyers

Meet Gary Shapiro and David Sternlieb, two experienced New Jersey attorneys who know how to get results. At Shapiro & Sternlieb, we are 100% dedicated to providing our clients with the highest quality legal representation. Through our hard work, persistence and with more than 60 years of combined legal experience, we work hard to protect your rights. As expert lawyers, we have the resources and knowledge to handle complex cases. We pride ourselves on our concern for you as an individual as well as for your legal rights.

Shapiro & Sternlieb: New Jersey Personal Injury Lawyers

auto accident lawyer ,NJ Personal Injury Lawyers, New Jersey Medical Malpractice Attorney

At Shapiro & Sternlieb, your case is our priority. Our attorneys combine outstanding client services with a thorough knowledge of the law and a firm understanding of the latest technology available. Our vast network of legal, medical and professional experts are available to present the best case for you. Located in Manalapan, New Jersey, our lawyers maintain flexible hours to meet your needs. We offer morning, evening or weekend hours, as well as visits to home or hospital, if needed. Our attorneys and staff bring the highest standards of expertise, preparation, concern, diligence, integrity and skill to each case. We take time to return your calls and to ensure each question is answered. You are included every step of the way!

News & Articles

Salmonella Outbreak Linked To Tainted Peanut Butter
CARBON NANOTUBES: A Closer Look at Miracle Technology's Potential Side Effects

Practice Areas

AsbestosInfant & Child Injuries
Auto AccidentsDUI (DWI) Matters
DiscriminationBirth Injuries
Defective ProductsBrain Injury
Burn InjuriesCerebral Palsy
Criminal DefenseClass Action Lawsuits
Construction AccidentsDog Bites
Erbs PalsyFailure To Diagnose Cancer
Gas ExplosionsHead Injury
Juvenile CourtLung Cancer - Mesothelioma
Medical MalpracticeMotorcycle Accidents
NegligenceNegligent Security
Nursing Home AbusePersonal Injury
Premises LiabilitySexual Harassment
Slip & Fall AccidentsTraffic Violations
Truck AccidentsWorkplace Injuries
Wrongful Discharge

FDA Consumer Health Information Updates

Mammography: What You Need to Know

Fri, 21 Oct 2016 09:00:00 -0400

Mammograms are still the best tool for breast cancer screening. As we observe Breast Cancer Awareness Month this October, learn how FDA certifies facilities that perform mammography, and clears and approves mammography devices, to help keep you safe.

Dianne Murphy: A Unique Insight Into the World of Pediatric Medicine

Wed, 19 Oct 2016 08:00:00 -0400

As Director of the Office of Pediatric Therapeutics at the Food and Drug Administration (FDA) since 2003, Dianne Murphy has had a front-row seat to the world of pediatric therapeutics. FDA interviews Dr. Murphy about her tenure here.

Dealing with ADHD: What You Need to Know

Wed, 12 Oct 2016 08:45:00 -0400

Studies show that the number of children being diagnosed with ADHD continues to increase. Learn to recognize and treat ADHD in kids and adults.

Making Decisions for Your Health: Getting the Info You Need

Tue, 04 Oct 2016 08:00:00 -0400

FDA is working hard to make sure you have the information you need to make informed decisions about your health.

What's in a Name? What Every Consumer Should Know About Foods and Flavors

Wed, 21 Sep 2016 08:00:00 -0400

Is flavor labeling on food packages misleading? FDA helps ensure that it isn't.

Food and Drug Administration--Press Releases

FDA grants accelerated approval to new treatment for advanced soft tissue sarcoma

Wed, 19 Oct 2016 13:51:00 -0400

The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues. Lartruvo is approved for use with the FDA-approved chemotherapy drug doxorubicin for the treatment of patients with STS who cannot be cured with radiation or surgery and who have a type of STS for which an anthracycline (chemotherapy) is an appropriate treatment.

FDA awards 21 grants to stimulate product development for rare diseases

Mon, 17 Oct 2016 12:38:00 -0400

The U.S. Food and Drug Administration today announced that it has awarded 21 new clinical trial research grants totaling more than $23 million over the next four years to boost the development of products for patients with rare diseases. These new grants were awarded to principal investigators from academia and industry with research spanning domestic and international clinical sites.

FDA warns against the use of homeopathic teething tablets and gels

Fri, 30 Sep 2016 15:09:00 -0400

The U.S. Food and Drug Administration is warning consumers that homeopathic teething tablets and gels may pose a risk to infants and children. The FDA recommends that consumers stop using these products and dispose of any in their possession.

FDA Statement from Todd Simpson, FDA Chief Information Officer (CIO) on GAO Report Regarding FDA’s IT Security Program

Thu, 29 Sep 2016 12:21:00 -0400

Information security and the protection of industry and public health information are among the FDA’s highest priorities and we do not take lightly the recommendations provided by the GAO in its June 2016 report.

FDA approves first automated insulin delivery device for type 1 diabetes

Wed, 28 Sep 2016 13:09:00 -0400

The U.S. Food and Drug Administration today approved Medtronic’s MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.

Recall Listing[min]&field_rc_date_value[max]&field_rc_heading_value=&field_rc_hazard_description_value=&field_rc_manufactured_in_value=&field_rc_manufacturers_value=